Angola vs Cote d'Ivoire: Population requiring preventive chemotherapy for schistosomiasis
Angola
5.62 million
in 2024
Cote d'Ivoire
8.30 million
in 2024
Angola rank
13th
Cote d'Ivoire rank
10th
Population requiring preventive chemotherapy for schistosomiasis over time
- Angola
- Cote d'Ivoire
How they compare
Cote d'Ivoire currently reports 8.30 million against 5.62 million in Angola, a difference of 2.69 million.
That makes Cote d'Ivoire's figure about 1.5 times Angola's.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Angola ahead.
Angola ranks 13th and Cote d'Ivoire ranks 10th of 52 countries.
Across the 2 decades both report, Angola averaged higher in 1 and Cote d'Ivoire in 1.
Head to head by decade
| Decade | Angola | Cote d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.53 million | 4.22 million | 1.30 million | Angola |
| 2020s | 5.29 million | 6.94 million | 1.65 million | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Angola or Cote d'Ivoire?
- Cote d'Ivoire, at 8.30 million against 5.62 million in Angola as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Angola and Cote d'Ivoire?
- 2.69 million, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Angola and Cote d'Ivoire?
- 15 years are reported by both, from 2010 to 2024.
- How do Angola and Cote d'Ivoire rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Angola ranks 13th and Cote d'Ivoire ranks 10th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.